Profund Advisors LLC Amicus Therapeutics, Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 83,172 shares of FOLD stock, worth $820,907. This represents 0.03% of its overall portfolio holdings.

Number of Shares

83,172

Previous 86,935 4.33%

Holding current value

$820,907

Previous $862,000 3.02%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$9.55 - $12.09 $35,936 - $45,494	-3,763 Reduced 4.33%	83,172 $888,000
Q2 2024 Aug 13, 2024	SELL	$9.04 - $11.75 $292,199 - $379,795	-32,323 Reduced 27.1%	86,935 $862,000
Q1 2024 May 08, 2024	SELL	$11.43 - $14.24 $150,281 - $187,227	-13,148 Reduced 9.93%	119,258 $1.4 Million
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $101,684 - $148,089	10,199 Added 8.35%	132,406 $1.88 Million
Q3 2023 Nov 13, 2023	BUY	$11.78 - $13.86 $17,410 - $20,485	1,478 Added 1.22%	122,207 $1.49 Million
Q2 2023 Aug 10, 2023	BUY	$10.72 - $13.3 $78,127 - $96,930	7,288 Added 6.42%	120,729 $1.52 Million
Q1 2023 May 11, 2023	BUY	$10.91 - $13.54 $979,532 - $1.22 Million	89,783 Added 379.5%	113,441 $1.26 Million
Q4 2022 Feb 02, 2023	BUY	$9.89 - $12.7 $13,519 - $17,360	1,367 Added 6.13%	23,658 $288,000
Q3 2022 Nov 04, 2022	SELL	$9.82 - $12.75 $3,427 - $4,449	-349 Reduced 1.54%	22,291 $233,000
Q2 2022 Aug 01, 2022	SELL	$6.23 - $11.12 $2,186 - $3,903	-351 Reduced 1.53%	22,640 $243,000
Q1 2022 May 10, 2022	SELL	$7.89 - $12.48 $12,908 - $20,417	-1,636 Reduced 6.64%	22,991 $218,000
Q4 2021 Feb 08, 2022	BUY	$9.82 - $12.44 $17,037 - $21,583	1,735 Added 7.58%	24,627 $284,000
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $38,106 - $51,622	-4,360 Reduced 16.0%	22,892 $219,000
Q2 2021 Aug 12, 2021	BUY	$8.71 - $10.72 $20,651 - $25,417	2,371 Added 9.53%	27,252 $262,000
Q1 2021 May 14, 2021	BUY	$9.2 - $23.86 $12,622 - $32,735	1,372 Added 5.84%	24,881 $246,000
Q4 2020 Feb 09, 2021	BUY	$13.47 - $24.89 $18,467 - $34,124	1,371 Added 6.19%	23,509 $543,000
Q3 2020 Nov 13, 2020	SELL	$12.89 - $15.89 $15,003 - $18,495	-1,164 Reduced 5.0%	22,138 $313,000
Q2 2020 Aug 03, 2020	BUY	$8.86 - $15.69 $13,919 - $24,648	1,571 Added 7.23%	23,302 $351,000
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $20,407 - $34,350	-3,078 Reduced 12.41%	21,731 $201,000
Q4 2019 Feb 18, 2020	BUY	$7.48 - $10.75 $32,552 - $46,784	4,352 Added 21.27%	24,809 $242,000
Q3 2019 Nov 12, 2019	SELL	$8.02 - $13.25 $19,272 - $31,839	-2,403 Reduced 10.51%	20,457 $164,000
Q2 2019 Aug 13, 2019	BUY	$10.96 - $14.4 $27,904 - $36,662	2,546 Added 12.53%	22,860 $285,000
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $71,444 - $99,054	-7,116 Reduced 25.94%	20,314 $276,000
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $85,903 - $137,773	-10,251 Reduced 27.2%	27,430 $263,000
Q3 2018 Nov 13, 2018	BUY	$11.6 - $16.54 $437,099 - $623,243	37,681 New	37,681 $456,000

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.77B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Amicus Therapeutics, Inc. Transaction History